Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss from continuing operations	$ (1,370,585)	$ (681,655)
Adjustments to reconcile net loss to net cash used in operating activities:
Recovery of previously written off receivables		(175,000)
Depreciation expense	1,046
Gain on sale of subsidiary assets	(1,548,998)
Stock-based compensation	733,748	59,154
Amortization of debt discounts	43,050	135,655
Impairment of fixed assets		55,000
Amortization of right-of-use asset	17,569
Loss on debt extinguishment	956,494
Decrease (increase) in assets:
Other current assets	(60,454)	4,169
Increase (decrease) in liabilities:
Accounts payable	(30,321)	(78,465)
Accrued expenses	(136,224)	108,694
Accrued expenses – related parties	13,533	(42,421)
Lease liability	(11,309)
Net cash (used in) operating activities from continuing operations	(1,392,451)	(614,869)
Net cash provided by operating activities from discontinued operations	358,576	727,394
Net cash provided by (used in) operating activities	(1,033,875)	112,525
Cash flows from investing activities
Purchase of fixed assets	(27,655)
Proceeds from sale of subsidiary net assets	2,173,439
Proceeds from sale of collateralized assets		275,000
Net cash (used) in investing activities from continuing operations	2,145,784	275,000
Net cash (used) in investing activities from discontinued operations		(11,667)
Net cash (used) in investing activities	2,145,784	263,333
Cash flows from financing activities
Repayments of notes payable	(595,965)	(100,000)
Repayments on convertible notes	(650,000)
Payments of deferred offering costs	(30,000)
Repurchase of Series C Preferred stock		(100)
Net cash provided by (used in) financing activities	(1,275,965)	(100,100)
Net cash used in financing activities from discontinued operations	(15,784)	(60,920)
Net cash provided by (used in) financing activities	(1,291,749)	(161,020)
Net increase (decrease) in cash	(179,840)	214,838
Cash - beginning	271,006	56,168
Cash - ending	91,166	271,006
Supplemental disclosures:
Interest paid	266,533	227,691
Income taxes paid
Non-cash investing and financing activities:
Addition of accounts payable and accrued interest into note payable	30,965
Common stock issued for conversion of note payable	40,000
Initial right-of-use asset valuation	74,575
Common stock issued for settlement of stock payable		71,745
Transfer of completed assets		6,076
Warrants issued for debt financing		93,938
Common stock issued for settlement of related party accrued compensation		$ 138,000